The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enhanced anti-ovarian cancer efficacy with MSLN-chimeric antigen receptor T cells secreting anti-CD39 antibody.
 
Haiyan Zhu
Employment - Tongji University
Research Funding - Tongji University
 
Xiaopei Li
Employment - Oricell Therapeutics
Patents, Royalties, Other Intellectual Property - Oricell Therapeutics Co.,Ltd
 
Qi Deng
Employment - Oricell Therapeutics
Research Funding - Oricell Therapeutics
Patents, Royalties, Other Intellectual Property - Oricell Therapeutics Co.,Ltd
 
Yuchen Zhang
Employment - Shanghai Key Laboratory of Maternal Fetal Medicine Shanghai, Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University
Research Funding - Oricell Therapeutics; Shanghai Key Laboratory of Maternal Fetal Medicine Shanghai, Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University
 
Huajing Wang
Employment - Oricell Therapeutics
Research Funding - Oricell Therapeutics
Patents, Royalties, Other Intellectual Property - Oricell Therapeutics Co.,Ltd
 
Xiaowen He
Employment - Oricell Therapeutics
Leadership - Oricell Therapeutics
Stock and Other Ownership Interests - Oricell Therapeutics
Research Funding - Oricell Therapeutics
Patents, Royalties, Other Intellectual Property - Oricell Therapeutics Co.,Ltd
 
Xian-Yang Li
Employment - Oricell Therapeutics
Research Funding - Oricell Therapeutics